51724-3
LaboratoryCefuroxime [Susceptibility]
Definition
From NCCLS although there are two formulations for cefuroxime, one for parenteral and one for oral administration, there is only one disk for laboratory testing. However, Different interpretive criteria were developed based on the different pharmacodynamic/pharmacokinetic data and clinical indications for the two formulations.
LOINC 6-Axis Classification
Component
Cefuroxime
Property
Susc
Time Aspect
Pt
System
Isolate
Scale Type
OrdQn
Method Type
N/A
Details
Class
ABXBACT
Order/Observation
Both
Short Name
Cefuroxime Susc Islt
Display Name
Cefuroxime [Susc]
Related Names
Frequently Asked Questions
What is LOINC code 51724-3?
LOINC code 51724-3 identifies "Cefuroxime [Susceptibility]". From NCCLS although there are two formulations for cefuroxime, one for parenteral and one for oral administration, there is only one disk for laboratory testing. However, Different interpretive criteria were developed based on the different pharmacodynamic/pharmacokinetic data and clinical indications for the two formulations.
What does 51724-3 measure?
This code measures Cefuroxime in Isolate. It belongs to the ABXBACT class in the LOINC classification.
What is LOINC?
LOINC (Logical Observation Identifiers Names and Codes) is a universal standard for identifying laboratory and clinical observations. It is maintained by the Regenstrief Institute and used worldwide for health data exchange.